Skip to main content
. 2018 Jul 31;35(8):1140–1152. doi: 10.1007/s12325-018-0753-6

Fig. 4.

Fig. 4

Physician assessment of a. Ease of use* and b. Time taken to teach Easyhaler® use** (asthma: n = 617; COPD: n = 775; ACO: n = 98). *Evaluated at visits 1–3 (through 12 weeks’ treatment with the Bufomix Easyhaler®); **evalauted at visit 1, after initial teaching of Easyhaler use to the patient by the physician. ACO asthma-COPD overlap